10 results on '"de Marinis, P."'
Search Results
2. 9161 FLEX study: Prognostic factors in NSCLC.
3. 9056 Evaluating the efficacy of zoledronic acid for the prevention of disease progression in patients with non-small cell lung cancer (NSCLC).
4. EGFR mutations in patients with non-small cell lung cancer (NSCLC) and correlation with sensitivity to erlotinib.
5. Activity and tolerability of Cisplatin (CDDP) and Fotemustine (FTM) combination in the treatment of patients with non-small cell lung cancer (NSCLC) with brain metastases (BM): A multicentric phase II study of the Gruppo Oncologico dell’Italia ...
6. 1BA Phase III study of pemetrexed plus cisplatin versus gemcitabine plus cisplatin in chemonaive patients with locally advanced or metastatic non-small cell lung cancer (NSCLC).
7. 817 Optimized schedule of gemcitabine (G), paclitaxel (T) and cisplatin (P) in the treatment of stage IIIB/IV non-small cell lung cancer (NSCLC): results of a phase II study.
8. 815 Elderly patients (pts) with unresectable localised or metastatic non-small-cell-lung-cancer (NSCLC): results of a phase II study with oral navelbineâ (nvb) given as a weekly monotherapy and first line treatment.
9. 798 Impact of third line ZD 1839 therapy on patients with advanced non-small cell lung cancer (NSCLC) who had failed prior platinum and/or docetaxel-based regimens (Astra Zeneca Expanded Access Programme).
10. 793 Multicenter phase II study of gemcitabine-oxaliplatin (GEMOX) chemotherapy in untreated locally advanced or metastatic non-small cell lung cancer (NSCLC) patients.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.